Author: Scott Redler

The Medicare advisory panel voted today in favor of Provenge coverage, Dendreon Corporation’s (DNDN) prostate cancer drug. The panel recommends that Medicare cover the treatment based on its survival benefits. The vote was...

Shares of Dendreon Corporation (DNDN) were halted this morning at 7:00 AM pending the release of pivotal news out of the Medicare advisory panel and remain so currently. I wrote yesterday that the company’s short-term fate...

Debunking QE2 Criticisms (Wall St Cheat Sheet)The merits of QE2 have been tirelessly debated, but when examining the harsh criticisms of the Fed’s latest action you must sift through the misrepresentations that have been...

Pretty Good for Government Work By WARREN E. BUFFETT DEAR Uncle Sam, My mother told me to send thank-you notes promptly. I’ve been remiss. Let me remind you why I’m writing. Just over two years ago, in September 2008, our...

Potash Corporation of Saskatchewan (POT) announced last night the authorization of a $2 billion share buyback plan. At yesterday’s closing prices the buyback could represent approximately 5% of shares outstanding. While...

For the first time in a long time market participants are getting paid both long and short. I covered most my shorts yesterday around the 1185 area in the S&P and will start testing levels for a bounce.  Be very stock...

A Medicare advisory panel is scheduled to vote tomorrow on whether to accept Dendreon Corporation’s (NASDAQ:DNDN) prostate cancer drug, Provenge. The fate of the company, and certainly its stock price, in the near term...

Hi, I’m Steve Levay and I’m a trading addict. I’ll admit it. Nothing gets the adrenaline pumping like that 9:30am opening bell. I love to sit at my desk and watch the up and down ticks of the market all day long. Despite...

Last week we started seeing some choppy, erratic action in the indices and leading stocks. Stocks on my “go-to list” started breaking their upper ranges and getting into some cash was a good idea. We noted that the trade has...

Recently saw a couple of these xtranormal videos and felt compelled to share. Hilarious, and make it easy for the layperson to understand these oft-blogged-about topics. Stay tuned for some potential T3Live blog originals. . ....